coiell产品代理
coiell产品代理
在培养物中维持活的人类细胞并防止它们受到污染的能力导致了脊髓灰质炎研究的一个关键突破：它使科学家能够培育脊髓灰质炎病毒并致力于开发第一种疫苗。但也许科里尔博士最经久不衰的遗产是他对知识的慷慨，以及他将科学家聚集在一起探索研究问题和合作解决方案的能力。
今天，Coriell 的使命是通过生产世界一流的生物材料并在生物样本库、个性化医疗和干细胞生物学方面进行开创性研究，加速科学发现。
我们在多个方面致力于了解人类遗传疾病。 Coriell Personalized Medicine Collaborative® (CPMC®) 研究旨在了解遗传信息在临床护理中的有用性。我们还通过在诱导多能干细胞 (iPSC) 研究中发挥重要作用，巩固我们在细胞生物学领域的历史。 Coriell 的生物库管理着世界上最多样化的细胞系、DNA 和其他生物材料，这些材料收集和分发给国际生物医学研究界使用。事实上，在 1960 年，Coriell 是美国国立卫生研究院认可的首批两个官方细胞库之一。
在 Coriell，我们每天都以创业精神迎接挑战，并以敏捷和专注来应对挑战。员工和科学家就支持我们共同愿景的想法展开合作。通过将这些科学思想转化为医学进步，Coriell 今天的创新证明了其开创性的过去。更重要的是，科瑞尔今天的创新是对您未来的承诺。
The Coriell Institute for Medical Research – originally known as South Jersey Medical Research Foundation and then as the
Institute for Medical Research– was founded by famed virologist Dr. Lewis L. Coriell in 1953. Dr. Coriell was a scientific pioneer, making invaluable contributions to biomedical research through advances in aseptic cell culture techniques and cryopreservation of cell lines.
The ability to sustain living human cells in culture – and keep them from being contaminated – led to a key breakthrough in polio research: it enabled scientists to grow the polio virus and work toward the first vaccine. But perhaps Dr. Coriell’s most enduring legacy was his generosity in knowledge and his ability to bring scientists together to explore research questions and collaborate on solutions.
Today, Coriell's mission is to accelerate scientific discovery by generating world-class biomaterials and conducting groundbreaking research in biobanking, personalized medicine and stem cell biology.
Our mission to understand human genetic disease is being pursued on several fronts. The Coriell Personalized Medicine Collaborative® (CPMC®) research study is seeking to understand the usefulness of genetic information in clinical care. We are also building upon our history in cell biology by playing an important role in induced pluripotent stem cell (iPSC) research. And Coriell’s biobank manages the world’s most diverse collection of cell lines, DNA, and other
international biomedical research community. In fact, in 1960 Coriell was one of the first two official cell banks recognized by the National Institute of Health.
At Coriell, we approach each day with an entrepreneurial energy and confront challenges with agility and focus. Staff and scientists collaborate on ideas that support our shared vision. By taking these scientific ideas and turning them into medical advances, Coriell’s innovation today is a testament to its pioneering past. More importantly, Coriell’s innovation today is a commitment to your future.
